General Practice Doctors in Clayton, GA - Medicare Status, Address, Contact

1 General Practice doctors found. Showing 1 - 1

Robin Lee Line, M.D.
General Practice
Medicare: Not Enrolled in Medicare
Practice Location: 773 N Main St, Clayton, GA 30525
Phone: 706-782-0468 Fax: 706-782-1488

News Archive

ACAAI scientific meeting to discuss pediatric allergies

Your child may be allergic to your holiday pumpkin pie, according to allergists at the annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Phoenix, Nov. 11-16. Hot topics discussed in pediatric allergies include pumpkin and caterpillar allergies, and outgrowing childhood allergies.

Care Support of America on overlooked healthcare issues in eldercare and family caregiving

As healthcare reform is being debated in Congress and on Main Street, vital and practical issues in eldercare and family caregiving are being overlooked. Some 30 million U.S. baby boomers are family caregivers for their aging parents, trying to keep their parents safe at home and helping them navigate the complexities of Medicare and manage an advancing illness. If they had their say, most elderly people would prefer to age in their own homes.

Cerulean initiates CRLX101 Phase 2 study in extensive-stage small cell lung cancer

Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a randomized Phase 2 study of its lead candidate, CRLX101, in patients with extensive-stage small cell lung cancer (SCLC) sensitive to first-line platinum-based chemotherapy.

Researchers discover potential method for neurodegenerative disease detection

New investigations, initiated by research workers at CIC bioGUNE and led by Dr. Aitor Hierro, have opened possibilities for making progress in the knowledge and prediction of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), according to the journal of The Proceedings of the National Academy of Sciences of the United States of America.This study opens the possibility of research in humans to detect this pathology before the symptoms arise.

Celera seeks FDA premarketing approval for KIF6 Genotyping Assay

Celera Corporation today announced that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration (FDA) for its KIF6 Genotyping Assay, a new molecular In Vitro diagnostic (IVD) test designed to detect a marker for risk of coronary heart disease (CHD) independent of traditional risk factors and aid clinical evaluation when statin treatment is being considered.

General Practice Doctors in Clayton, GA Accepting Medicare